Philips to Acquire SpectraWAVE to Enhance AI Coronary Imaging
TL;DR Summary
Philips is acquiring SpectraWAVE to enhance its portfolio of AI-powered coronary intravascular imaging and physiological assessment technologies, including HyperVue Imaging System and X1-FFR, aiming to improve outcomes in coronary artery disease treatment through advanced, integrated, and AI-supported solutions.
Topics:business#ai#coronary-artery-disease#healthcaremedical-technology#intravascular-imaging#philips#spectrawave
- Philips agrees to acquire SpectraWAVE Inc. Philips
- Royal Philips (NYSE: PHG) to acquire SpectraWAVE, adding AI coronary imaging tools Stock Titan
- Philips claims AI coronary imaging developer SpectraWAVE Fierce Biotech
- Philips doubles down on image-guided therapy with SpectraWAVE acquisition Yahoo Finance
- Philips to Buy US-based Medical Imaging Company SpectraWAVE marketscreener.com
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
7 min
vs 8 min read
Condensed
97%
1,486 → 38 words
Want the full story? Read the original article
Read on Philips